Back to Journals » Breast Cancer: Targets and Therapy » Volume 14

Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States

Total article views   HTML views PDF downloads Totals
4,347 Dovepress* 3,919+ 185 4,104
PubMed Central* 428 199 627
Totals 4,347 384 4,731
*Since 9 December 2022

View citations on PubMed Central and Google Scholar